View Older Stories View More Recent Stories

Nov 1, 2021 08:30AM Wave Life Sciences to Webcast Conference Call of Third Quarter 2021 Financial Results on November 10, 2021
Nov 1, 2021 08:30AM Wave Life Sciences to Webcast Conference Call of Third Quarter 2021 Financial Results on November 10, 2021
Oct 18, 2021 05:01PM WAVE Life Sciences (WVE) Amends Collaboration with Takeda
Oct 18, 2021 05:00PM Wave Life Sciences and Takeda Amend CNS Collaboration
Oct 18, 2021 05:00PM Wave Life Sciences and Takeda Amend CNS Collaboration
Sep 29, 2021 08:30AM Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a Clinical Trial of WVE-N531 in Duchenne Muscular Dystrophy
Sep 29, 2021 08:30AM Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a Clinical Trial of WVE-N531 in Duchenne Muscular Dystrophy
Sep 28, 2021 04:05PM WAVE Life Sciences (WVE) Announces New Data for Leading RNA Editing Capability Across Multiple Tissues and Provides Update on AATD Program During Analyst and Investor Research Webcast
Sep 28, 2021 04:05PM Wave Life Sciences Announces New Data for Leading RNA Editing Capability Across Multiple Tissues and Provides Update on AATD Program During Analyst and Investor Research Webcast
Sep 28, 2021 04:05PM Wave Life Sciences Announces New Data for Leading RNA Editing Capability Across Multiple Tissues and Provides Update on AATD Program During Analyst and Investor Research Webcast
Sep 22, 2021 04:05PM Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference
Sep 22, 2021 04:05PM Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference
Sep 9, 2021 08:30AM Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease
Sep 9, 2021 08:30AM Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease
Sep 8, 2021 08:30AM Wave Life Sciences to Highlight RNA Editing Capability and AATD and Neurology Programs at 2021 Analyst and Investor Research Webcast on September 28, 2021
Sep 8, 2021 08:30AM Wave Life Sciences to Highlight RNA Editing Capability and AATD and Neurology Programs at 2021 Analyst and Investor Research Webcast on September 28, 2021
Sep 7, 2021 04:05PM Wave Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Sep 7, 2021 04:05PM Wave Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Sep 7, 2021 08:30AM Wave Life Sciences to Highlight RNA Editing Modality and PRISM Platform Advancements During Upcoming Scientific Conferences
Sep 7, 2021 08:30AM Wave Life Sciences to Highlight RNA Editing Modality and PRISM Platform Advancements During Upcoming Scientific Conferences
Aug 5, 2021 07:30AM Wave Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
Aug 5, 2021 07:30AM Wave Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
Jul 26, 2021 04:05PM Wave Life Sciences to Webcast Conference Call of Second Quarter 2021 Financial Results on August 5, 2021
Jul 26, 2021 04:05PM Wave Life Sciences to Webcast Conference Call of Second Quarter 2021 Financial Results on August 5, 2021
Jul 20, 2021 08:00AM Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a FOCUS-C9 Clinical Trial of WVE-004 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Jul 20, 2021 08:00AM Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a FOCUS-C9 Clinical Trial of WVE-004 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Jun 2, 2021 04:54PM WAVE Life Sciences (WVE) Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency
Jun 2, 2021 04:52PM Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency
Jun 2, 2021 04:52PM Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency
May 28, 2021 08:30AM Wave Life Sciences to Present at Jefferies Virtual Healthcare Conference
May 28, 2021 08:30AM Wave Life Sciences to Present at Jefferies Virtual Healthcare Conference
May 13, 2021 07:30AM Wave Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
May 13, 2021 07:30AM Wave Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
May 10, 2021 04:05PM Wave Life Sciences to Present at RBC Capital Markets Global Healthcare Virtual Conference
May 10, 2021 04:05PM Wave Life Sciences to Present at RBC Capital Markets Global Healthcare Virtual Conference
May 3, 2021 04:05PM Wave Life Sciences to Webcast Conference Call of First Quarter 2021 Financial Results on May 13, 2021
May 3, 2021 04:05PM Wave Life Sciences to Webcast Conference Call of First Quarter 2021 Financial Results on May 13, 2021
Mar 29, 2021 04:08PM Wave Life Sciences (WVE) Provides Update on Phase 1b/2a PRECISION-HD Trials
Mar 29, 2021 04:05PM Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials
Mar 29, 2021 04:05PM Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials
Mar 19, 2021 08:00AM Wave Life Sciences to Present at the Third Annual Stifel CNS Day
Mar 19, 2021 08:00AM Wave Life Sciences to Present at the Third Annual Stifel CNS Day
Mar 4, 2021 07:00AM Wave Life Sciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Mar 4, 2021 07:00AM Wave Life Sciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 23, 2021 08:00AM Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
Feb 23, 2021 08:00AM Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
Feb 16, 2021 05:00PM Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference  
Feb 16, 2021 05:00PM Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference  
Jan 11, 2021 08:00AM Wave Life Sciences Highlights Pipeline Progress and Expansion Leveraging New PN Backbone Chemistry Modifications
Jan 11, 2021 08:00AM Wave Life Sciences Highlights Pipeline Progress and Expansion Leveraging New PN Backbone Chemistry Modifications
View More Recent Stories View Older Stories